The Pharmacologic Rationale for the Clinical Use of Antidepressants

Article Abstract

Click to enlarge page

Mirtazapine is the latest in a line of drugs that have recently been introduced for the treatment of depression. It is now available worldwide and has been used in more than 170,000 patients (May 1997). The novelty of this drug over other antidepressants lies particularly in its unique mechanism of action.

Mirtazapine inhibits neither the reuptake of norepinephrine (NE), serotonin (5-HT), or dopamine (DA) nor the activity of monoamine oxidase, thereby clearly being distinguished from the tricyclic antidepressants (TCAs), newer reuptake inhibitors of either serotonin and/or norepinephrine (SSRI/SNRI), and the monoamine oxidase inhibitors (MAOIs).

J Clin Psychiatry 1997;58(11):501-508

Related Articles

Volume: 58

Quick Links: Depression

Continue Reading…